Open access · CC-BY
via OpenAlex
UA-30 ameliorates motor deficits through RalA-mediated mitophagy in ALS mice
Bingge Zhang, Ye He, Ting Su, Xiaomei Li, Xiufen Zhang, Ruijuan Liu, Xiao Han, Ruiming Zhang, Chao Yang, Xinlei Liu, Qinghua Hou, Zaijun Zhang, Xie Yongmei, Gongping Liu, Xifei Yang
Journal of Clinical Investigation · 2026
Mitochondrial dysfunction
Altered intercellular communication
Chronic inflammation
Disabled macroautophagy
Human
Mouse
Preclinical / animal
Abstract
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive motor neuron loss, skeletal muscle atrophy, paralysis, and eventually death. Mitochondrial dysfunction(definition) plays a pivotal role in ALS pathogenesis, although the precise pathogenic mechanisms remain elusive, and effective therapeutic strategies are extremely limited. In this study, we developed a small-molecule inhibitor, UA-30, which directly targets RalA, and explored its potential for the treatment of ALS. We found that when administered via oral gavage for 6 weeks following the onset of motor deficit, UA-30 extended lifespan and improved motor function of SOD1G93A mice, a model of ALS. UA-30 ameliorated motor neuron loss, neuroinflammation, fibrosis, and mitochondrial dysfunction, as evidenced by energy recovery, decreased oxidative stress, and enhanced mitophagy. Mechanistically, UA-30 inhibited RalA activity and thereby modulated ERK/FOXO3a signaling, which inhibited FOXO3a degradation via the ubiquitin-proteasome pathway; enhanced FOXO3a stability; and upregulated the expression of mitophagy-related genes in this ALS mouse model. The beneficial effects of UA-30 in ALS were abolished by overexpression of the constitutively active form of RalA (RalAG23V) or Mdivi-1 treatment. These findings support RalA inhibition as a therapeutic strategy for enhancing mitophagy and mitigating ALS-like pathology and support UA-30 as an orally active candidate for further preclinical development.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1172/jci202787
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Zhang, B., He, Y., Su, T., Li, X., Zhang, X., Liu, R., Han, X., Zhang, R., Yang, C., Liu, X., Hou, Q., Zhang, Z., Yongmei, X., Liu, G., & Yang, X. (2026). UA-30 ameliorates motor deficits through RalA-mediated mitophagy in ALS mice. <em>Journal of Clinical Investigation</em>. https://doi.org/10.1172/jci202787
Vancouver
Zhang B, He Y, Su T, Li X, Zhang X, Liu R, et al. UA-30 ameliorates motor deficits through RalA-mediated mitophagy in ALS mice. Journal of Clinical Investigation. 2026. doi:10.1172/jci202787.
BibTeX
@article{bingge2026UAamel,
title = {UA-30 ameliorates motor deficits through RalA-mediated mitophagy in ALS mice},
author = {Bingge Zhang and Ye He and Ting Su and Xiaomei Li and Xiufen Zhang and Ruijuan Liu and Xiao Han and Ruiming Zhang and Chao Yang and Xinlei Liu and Qinghua Hou and Zaijun Zhang and Xie Yongmei and Gongping Liu and Xifei Yang},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci202787},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Experimental Neurology 2020
Open access · CC-BY
Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of modulating NAD+ levels in hSOD1-linked ALS mouse models
Frontiers in Molecular Neuroscience 2017
Open access · CC-BY
Autophagy Dysregulation in ALS: When Protein Aggregates Get Out of Hand
Phytomedicine : international journal of phytotherapy and phytopharmacology 2026
Citation only
Ginsenoside Ro ameliorates d-galactose-induced sarcopenia by modulating oxidative stress, inflammation, and gut microbiota in mice.
Aging and Disease 2025
Open access · CC-BY
Pharmacological Activation of Mitophagy Confers Neuroprotective Benefits for Amyotrophic Lateral Sclerosis
bioRxiv (Cold Spring Harbor Laboratory) 2020
Preprint · CC-BY
Transplantation of Muscle Stem Cell Mitochondria Rejuvenates the Bioenergetic Function of Dystrophic Muscle
Frontiers in Bioengineering and Biotechnology 2020
Open access · CC-BY